foxo4-dri senolytic peptide animal model 2024

foxo4-dri senolytic peptide animal model 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI Peptide - Nationwide Peptides

Name: foxo4-dri senolytic peptide animal model 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI Peptide - Nationwide Peptides
Brand: astonvaughan.co.uk
SKU: 8025393667
Price: 28.35 USD
Availability: InStock
Rating: 4.1332 (19 reviews)

FOXO4 DRI Peptide Nationwide Peptides By National Science Labs, LLC FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging FOXO4 peptide targets myofibroblast ameliorates bleomycininduced pulmonary fibrosis in mice through ECMreceptor interaction pathway Han 2022 Journal of Cellular and Molecular Medicine Wiley Online Library Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics

SKU: 8025393667 · From astonvaughan.co.uk

4.1

USD28.35 USD49.35

Pay in 4 interest-free payments of $7.09 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

In one of the four SCLC tumour tissues (25%) screened, preferential c-MET overexpression and activation of p-MET (both the phosphoepitopes pY1003 and pY1230/1234/1235) along the tumour expanding invasive front were identified (Figures 5A and B)